TransEnterix Senhance surgical robot gets approved for new procedures

TransEnterix has won expanded indications from the Food and Drug Administration for its Senhance robot-assisted surgical system. The system is now cleared for hernia and gallbladder procedures. There are approximately 760,000 inguinal hernia and 1.2 million laparoscopic cholecystectomy procedures performed annually in the U.S. With this clearance, the system’s total addressable annual procedures in theā€¦

The post TransEnterix Senhance surgical robot gets approved for new procedures appeared first on The Robot Report.